Amelia Azman1*, Andy Alfred Minson1, Ngu Lock Hock2, Muzhirah Aisha Md Haniffa2, Winnie Ong Peitee2, Keng Wee Teik2, Ch’ng Gaik Siew3, Yusnita Yakob1
1. Institute for Medical Research, National Institutes of Health, 50588 Kuala Lumpur, Malaysia
2. Genetic Clinic, Hospital Kuala Lumpur, 50586 Kuala Lumpur, Malaysia
3. Genetic Clinic, Hospital Pulau Pinang, 10450 George Town, Pulau Pinang, Malaysia
*Corresponding author: Amelia Azman.
ABSTRACT
INTRODUCTION: X-linked adrenoleukodystrophy (X-ALD) is a rare inherited peroxisomal disorder caused by pathogenic ABCD1 variants. It leads to a wide range of neurological and adrenal symptoms. The clinical spectrum varies from asymptomatic carriers to rapidly progressive cerebral forms, causing severe disability. While female carriers are typically asymptomatic, they may develop adrenomyeloneuropathy (AMN) or primary adrenocortical insufficiency later in life.
OBJECTIVE(S): This study aimed to characterise the ABCD1 mutation spectrum and clinical presentation of Malaysian patients with X-ALD, addressing the lack of local data.
MATERIALS & METHODS: Blood samples from patients suspected of having X-ALD, received between 2013 and 2024, were analysed by direct ABCD1 gene sequencing following informed consent. Clinical and genetic data from positive cases were retrospectively reviewed.
RESULTS: We identified 21 different ABCD1 pathogenic variants in 23 unrelated patients and 10 mothers or maternal relatives. Malays made up most patients (69.7%), followed by Chinese (15.2%), Sarawakian (6.1%), and others (9.1%). There were 22 probands, mostly male (90.9%), with a median diagnosis age of 7 years (range: 3–47) and a mean age of 10.7 years, reflecting a few older symptomatic females (aged 37 and 47). The variants were spread across the gene except exon 2, with two intronic variants and one gross deletion spanning intron 2 to exon 10; no mutation hot spot was seen. Five variants (23.8%) were novel. Missense variants were most common (57.1%), followed by frameshift (19.0%), splice site (9.5%), and nonsense, small deletion, and gross deletion variants (each 4.8%). Most variants (90.5%) were unique except c.1202G>A and c.1534G>A, each found in two unrelated families. Most probands had neuroregression with progressive cognitive, motor, and speech loss. Common features included seizures, spastic paraparesis, gait instability, vision or hearing loss, and MRI evidence of leukodystrophy. Some had adrenal insufficiency. Several asymptomatic female carriers were detected through family screening.
CONCLUSION: Our findings highlight significant genetic and phenotypic variability among Malaysian X-ALD patients.
KEYWORDS: X-linked Adrenoleukodystrophy (X-ALD), ABCD1, Mutation Spectrum, Rare Disease, X-linked Disease.


